Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Effects of supportive‐expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial

Open access
Kissane, David, Li, Yuelin·2008·Cancer

Abstract

Based on a very small subsample of 25 estrogen receptor (ER)-negative women with breast cancer, 13 of whom received group therapy, Spiegel et al.1 conducted an exploratory analysis that found increased survival for these women. They have argued that these women were not protected by hormonal therapies. In our much larger Australian study of group therapy with women with advanced breast cancer, there were 70 ER-negative women.2 Kaplan-Meier survival analysis showed no difference between the 43 hormone receptor-negative (estrogen) patients in the group intervention condition and the 27 hormone receptor-negative patients in the control condition. The median survival durations were at 15.5 months (95% confidence interval [CI], 9.5–25.8) for patients in the intervention condition and 17.2 months (95% CI, 8.1–26.5) for patients in the control condition, respectively. The log-rank test for equality of survivor functions was not statistically significant (chi-square (2) = 0.55, P = .46). We also tried to replicate their analytic method exactly. In a Cox proportional hazards model we tested the effect of a treatment by positive hormone receptor status interaction, after controlling for intervention site, intervention site by treatment interaction, a treatment main effect, and a positive hormone receptor status main effect. We also centered the predictors as recommended in Kraemer and Blasey,3 with coding of 1/2 and −1/2 in dichotomous variables (for both the randomization and hormone receptor status variables) and 1-1/m and −1/m for the site dummy variables (where m = 5 in our study). Again, the result was consistent with the Kaplan-Meier survival analysis. There was no hormone receptor status by treatment interaction (Cox proportional hazards B = 1.14, Wald statistic = 0.38, P = .71). Given our inability to replicate their latest exploratory finding, we conclude that it is a chance finding. Women should not be swayed into false hope, but appreciate that strong evidence has emerged that group therapy does not prolong survival. Group therapy does prevent depression and improve quality of life, thus representing a wonderful adjunctive psychosocial treatment for those with cancer. David Kissane MD*, Yuelin Li PhD*, * Department of Psychiatry & Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.23179

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 1

  1. 10.1002/mpr.170 · DOI · Paper page

Cited by

See all 197

Metadata

Authors
Kissane, D., & Li, Y.
Venue
Cancer
Publisher
Wiley
Published
2007-12-03
Volume
112
Issue
2
Pages
443-444
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2018026227
Cited by
197
References
11
FWCI
7.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of supportive‐expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. https://app.cochat.ai/papers/10.1002/cncr.23179
The paper
Kissane, D., & Li, Y. (2008). Effects of supportive‐expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. Cancer. https://doi.org/10.1002/cncr.23179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.